acetaminophen has been researched along with End Stage Liver Disease in 10 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We combined prospective data from the Acute Liver Failure Study Group (ALFSG) Registry with those of the Scientific Registry of Transplant Recipients (SRTR) to assess outcomes among consecutive patients with ALF listed for LT." | 1.91 | Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis. ( Durkalski, V; Fontana, RJ; Karvellas, CJ; Lake, JR; Lee, WM; Leventhal, TM; Parekh, JR; Rakela, JL; Reddy, KR; Stravitz, RT; Zhang, J, 2023) |
| "Acetaminophen was the most common causative agent." | 1.91 | Drug induced liver injury: causative agents and predictors for the outcome - a retrospective study at Tanta University Hospital, Egypt. ( Elbastawesy, SM; Elkadeem, M; Helal, NE; Mashaal, SA, 2023) |
| "Sixty-six (47." | 1.38 | The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose. ( Craig, DG; Davidson, JS; Hayes, PC; Martin, KG; Reid, TW; Simpson, KJ; Wright, EC, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 7 (70.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vazquez, JH | 1 |
| Kennon-McGill, S | 1 |
| Byrum, SD | 1 |
| Mackintosh, SG | 1 |
| Jaeschke, H | 1 |
| Williams, DK | 1 |
| Lee, WM | 4 |
| Dranoff, JA | 1 |
| McGill, MR | 1 |
| Karvellas, CJ | 1 |
| Leventhal, TM | 1 |
| Rakela, JL | 1 |
| Zhang, J | 1 |
| Durkalski, V | 1 |
| Reddy, KR | 1 |
| Fontana, RJ | 2 |
| Stravitz, RT | 2 |
| Lake, JR | 1 |
| Parekh, JR | 1 |
| Tujios, S | 1 |
| Helal, NE | 1 |
| Elkadeem, M | 1 |
| Elbastawesy, SM | 1 |
| Mashaal, SA | 1 |
| Kwan, R | 1 |
| Chen, L | 1 |
| Park, MJ | 1 |
| Su, Z | 1 |
| Weerasinghe, SVW | 1 |
| Durkalski-Mauldin, VL | 1 |
| Omary, MB | 1 |
| Yarema, MC | 1 |
| Johnson, DW | 1 |
| Sivilotti, MLA | 1 |
| Nettel-Aguirre, A | 1 |
| DeWitt, C | 1 |
| Gosselin, S | 1 |
| Murphy, N | 1 |
| Victorino, C | 1 |
| Bailey, B | 1 |
| Dong, K | 1 |
| Haney, E | 1 |
| Purssell, R | 1 |
| Thompson, M | 1 |
| Lord, JA | 1 |
| Spyker, DA | 1 |
| Rumack, BH | 1 |
| Nash, E | 1 |
| Sabih, AH | 1 |
| Chetwood, J | 1 |
| Wood, G | 1 |
| Pandya, K | 1 |
| Yip, T | 1 |
| Majumdar, A | 1 |
| McCaughan, GW | 1 |
| Strasser, SI | 1 |
| Liu, K | 1 |
| Di Giorgio, A | 1 |
| Nicastro, E | 1 |
| Dalla Rosa, D | 1 |
| Nebbia, G | 1 |
| Sonzogni, A | 1 |
| D'Antiga, L | 1 |
| Ford, RM | 1 |
| Sakaria, SS | 1 |
| Subramanian, RM | 1 |
| Craig, DG | 1 |
| Reid, TW | 1 |
| Wright, EC | 1 |
| Martin, KG | 1 |
| Davidson, JS | 1 |
| Hayes, PC | 1 |
| Simpson, KJ | 1 |
1 review available for acetaminophen and End Stage Liver Disease
| Article | Year |
|---|---|
Critical care management of patients before liver transplantation.
Topics: Acetaminophen; Acetylcysteine; Brain Edema; Drug Overdose; End Stage Liver Disease; Hepatopulmonary | 2010 |
9 other studies available for acetaminophen and End Stage Liver Disease
| Article | Year |
|---|---|
Proteomics Indicates Lactate Dehydrogenase Is Prognostic in Acetaminophen-Induced Acute Liver Failure Patients and Reveals Altered Signaling Pathways.
Topics: Acetaminophen; Biomarkers; End Stage Liver Disease; Humans; L-Lactate Dehydrogenase; Liver Failure, | 2022 |
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis.
Topics: Acetaminophen; Cohort Studies; End Stage Liver Disease; Humans; Liver Failure, Acute; Liver Transpla | 2023 |
Management of Acute Liver Failure: Update 2022.
Topics: Acetaminophen; End Stage Liver Disease; Humans; Liver Failure, Acute; Liver Transplantation; Severit | 2022 |
Drug induced liver injury: causative agents and predictors for the outcome - a retrospective study at Tanta University Hospital, Egypt.
Topics: Acetaminophen; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Child; Egypt; End St | 2023 |
The Role of Carbamoyl Phosphate Synthetase 1 as a Prognostic Biomarker in Patients With Acetaminophen-induced Acute Liver Failure.
Topics: Acetaminophen; Biomarkers; Carbamyl Phosphate; End Stage Liver Disease; Humans; Ligases; Liver Failu | 2023 |
Predicting mortality from acetaminophen poisoning shortly after hospital presentation.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Canada; Chemical and Drug Induced Liver Injury; Drug Overdo | 2021 |
Drug-induced liver injury in Australia, 2009-2020: the increasing proportion of non-paracetamol cases linked with herbal and dietary supplements.
Topics: Acetaminophen; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Antipyretics; Antitubercular Age | 2021 |
Transplant-free Survival in Chronic Liver Disease Presenting as Acute Liver Failure in Childhood.
Topics: Acetaminophen; Child; Child, Preschool; End Stage Liver Disease; Female; Graft Survival; Hepatic Enc | 2019 |
The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Biomarkers; Cohort Studies; End Stage Liver Disease; | 2012 |